If you have time, I suggest you look into the CHF phase III trial ... which I personally believe is very well designed. The benefit of recruiting the sickest patients with CHF, is that any benefit from treatment will be clearly visible in the data ... and I have a feeling that Teva will one day be feeling like the Dons after Sydney were done with them over the weekend!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)